EE376 Estimated Financial Impact of the Drug Cladribine Incorporation for the Relapsing-Remitting Multiple Sclerosis Treatment (RRMS) in a Health Insurance Company in Brazil
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.677
https://www.valueinhealthjournal.com/article/S1098-3015(23)00777-5/fulltext
Section Title :
Section Order :
10157
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00777-5&doi=10.1016/j.jval.2023.03.677